SeqensUP!
Up
SeqensUP!
SeqensUP! Empower your API
SEQENS new integrated offer to solve your challenges in early-stage development
Small molecules Drug candidates (APIs) require innovation in Drug Delivery Solutions in early-stage development due to low water solubility for example. Modifying the form of the Drug Candidate enables to:
- Enhance oral bioavailability
- Control releasing profile
- Increase stability
- Improve processability
SEQENS has extended its offer towards a comprehensive solution from Drug Substance to its early-phase formulation
- Development of phase-appropriate oral formulations
- Services for your preclinical ADME studies and for your first in human early clinical trials (phases I and IIa)
Our key expertises
SEQENS combines expertise to offer fully integrated services towards early clinical formulation, available also as standalone services:
- Solid State
- Pre-Formulation
- Early Formulation
- Early administrable forms
Services consist of innovative (technical) early formulation activities on drug substances (APIs). Any material supplies are not intended for clinical use.
Our differentiating features
SEQENS is at your service to solve your challenges in early-stage development with strong values:
- Time saving
- Cost leadership
- Agility
- Reliability
- Expertise & Innovation
